WCLC 2025 - Posters & ePosters-P1.17.44 Multiomic Interaction Among Host and Tumor Immunity for Chemo De-Escalation. People Phase II Trial, First Line Pembrolizumab in Low PD-L1 NSCLC

P1.17.44 Multiomic Interaction Among Host and Tumor Immunity for Chemo De-Escalation. People Phase II Trial, First Line Pembrolizumab in Low PD-L1 NSCLC

Back to course

Asset Subtitle

Cecilia Silvestri

Meta Tag

Speaker Cecilia Silvestri

Topic Global Health, Health Services, and Health Economics